Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Sep;14(9):4079-4081.
doi: 10.4103/jfmpc.jfmpc_113_25. Epub 2025 Sep 29.

Beyond anticholinergic effects: A case of trihexyphenidyl-induced bradycardia

Affiliations
Case Reports

Beyond anticholinergic effects: A case of trihexyphenidyl-induced bradycardia

Soumi Kundu et al. J Family Med Prim Care. 2025 Sep.

Abstract

Anticholinergic drugs are extensively employed in clinical settings, with their side effects well-documented. However, paradoxical bradycardia due to trihexyphenidyl hydrochloride, an anticholinergic agent, is an infrequent and underreported phenomenon. This may be attributed to a lack of vigilant monitoring in patients undergoing therapy. Here, we present the case of a 12-year-old girl who developed sinus bradycardia following the administration of trihexyphenidyl. The heart rate normalized upon drug discontinuation. This report emphasizes the need for thorough cardiac monitoring, including baseline heart rate, Electrocardiogram (ECG), and electrolyte evaluation, before initiating therapy to prevent adverse outcomes.

Keywords: Adverse drug reaction; paradoxical bradycardia; trihexyphenidyl hydrochloride.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Sinus bradycardia
Figure 2
Figure 2
Heart rate variability in response to Trihexyphenydyl hydrochloride

References

    1. Blumensohn R, Razoni G, Shalev A, Munitz H. Bradycardia due to trihexyphenidyl hydrochloride. Drug Intell Clin Pharm. 1986;20:786–7. - PubMed
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharacol Ther. 1981;30:239–45. - PubMed
    1. Kumar Panda P, Moirangthem V, Tomar A, Neyaz O, Sharawat IK. Efficacy of oral trihexyphenidyl plus clonazepam versus trihexyphenidyl for the treatment of dystonia in children with dystonic cerebral palsy: An open-label randomized controlled trial. Pediatr Neurol. 2024;158:35–40. - PubMed
    1. Chiappini S, Mosca A, Miuli A, Semeraro FM, Mancusi G, Santovito MC, et al. Misuse of anticholinergic medications: A systematic review. Biomedicines. 2022;10:355. - PMC - PubMed

Publication types

LinkOut - more resources